Skip to main content
. 2022 Jun 20;25(10):818–826. doi: 10.1093/ijnp/pyac036

Figure 1.

Figure 1.

The prescription rate of antipsychotic monotherapy at discharge. The prescription rate of antipsychotic monotherapy at discharge in the treatment-resistant schizophrenia (TRS) with clozapine group was significantly higher than that in the other groups. Fisher’s exact test adjusted by Bonferroni correction. *P < 6.2 × 10−4 was defined as significant. ND-TRS, no description of TRS.